Regulation

Filter

Current filters:

None

Popular Filters

2576 to 2600 of 2729 results

Sanofi and Regeneron mCRC drug Zaltrap misses goals but gets FDA priority

10-04-2012

The US Food and Drug Administration has granted priority review of the Biologics License Application…

BiotechnologyNorth AmericaPharmaceuticalRegeneronRegulationResearchSanofiZaltrap

Canadian patients wait two and a half years for new drug access

09-04-2012

As a result of government bureaucracies to approve new prescription drugs for public use, Canadians are…

North AmericaPharmaceuticalPoliticsPricingRegulation

EMA tightens conflicts-of-interests policies with immediate effect

04-04-2012

The European Medicines Agency yesterday published its updated policy on conflicts of interests of the…

BiotechnologyEuropePharmaceuticalRegulation

Bayer cancer drug candidate regorafenib improves survival in GIST

04-04-2012

German drug major Bayer (BAY: DE) yesterday announced positive results from its Phase III trial GRID…

BayerOncologyPharmaceuticalregorafenibRegulationResearch

FDA approves UCB drug Neupro for PD and RLS

03-04-2012

Belgian drugmaker UCB (Euronext Brussels: UCB) said yesterday that the US Food and Drug Administration…

NeuproNeurologicalNorth AmericaPharmaceuticalRegulationUCB

Eisai breast cancer drug still viewed as not cost effective by NICE

03-04-2012

In a third rejection, the UK drug watchdog the National Institute for Health and clinical Excellence…

EisaiEuropeHalavenOncologyPharmaceuticalPricingRegulation

Roche to file for trastuzumab emtansine this year, on positive Ph III results

03-04-2012

Swiss drug major Roche (ROG: SIX) says that top-line results of EMILIA, the first randomized Phase III…

BiotechnologyGenentechGlaxoSmithKlineOncologyPharmaceuticalRegulationResearchRochetrastuzumab

FDA OKs pregnancy use of Novo Nordisk diabetes therapy Levemir

02-04-2012

The US Food and Drug Administration has approved Levemir (insulin detemir [rDNA origin] injection), from…

DiabetesLevemirNorth AmericaNovo NordiskPharmaceuticalRegulation

Poland breaking EU law by allowing unauthorized cheaper drugs

02-04-2012

Polish legislation authorizing the placing on the market of foreign medicinal products lacking authorization…

EuropeGenericsLegalMarkets & MarketingPharmaceuticalRegulation

German IQWiG finds mixed added benefits for Eliquis

02-04-2012

In an early benefit assessment under the Act on the Reform of the Market for Medicinal Products (AMNOG),…

Bristol-Myers SquibbCardio-vascularEliquisEuropePfizerPharmaceuticalPricingRegulation

Genzyme and Isis file Kynamro NDA in USA

02-04-2012

Biotech firm Genzyme, a subsidiary of French drug major Sanofi (Euronext: SAN), has submitted a New Drug…

Cardio-vascularGenzymeIsis PharmaceuticalsKynamroNorth AmericaPharmaceuticalRare diseasesRegulationSanofi

BIO supports sufficient appropriations for FDA on BsUFA and PDUFA; backed by GPhA

01-04-2012

The Biotechnology Industry Organization (BIO) has expressed its support for funding of the Food and Drug…

BiotechnologyFinancialNorth AmericaPharmaceuticalRegulation

NICE recommendations on Bayer's Xarelto and Amgen Xgeva's for UK NHS use

30-03-2012

Following the receipt of further evidence from Bayer HealthCare, a unit of German drugmaker Bayer (BAY:…

AmgenBayerCardio-vascularEuropeOncologyPharmaceuticalPricingRegulationXareltoXgeva

FDA calls for more data from Chelsea Thera on Northera

30-03-2012

The US Food and Drug Administration has issued a complete response letter regarding the New Drug Application…

BiotechnologyChelsea TherapeuticsNeurologicalNorth AmericaNortheraRegulation

Bipartisan Bill to strengthen testing of pediatric drugs launched in USA

29-03-2012

US Representative Mike Rogers (Republican, Michigan) this week introduced bipartisan legislation with…

BiotechnologyLegalNorth AmericaPharmaceuticalRegulationResearch

Medicines registration harmonization program for East Africa launches

29-03-2012

The NEPAD Agency, on behalf of the African Medicines Regulatory Harmonization (AMRH) Program partners…

PharmaceuticalRegulationRest of the World

Botox shows efficacy in idiopathic overactive bladder, says Allergan

29-03-2012

USA-based Allergan (NYSE: AGN) announced that two Phase III clinical trials of Botox (onabotulinumtoxinA),…

AllerganBotoxGenito-urinaryPharmaceuticalRegulationResearch

QRxPharma value assed as Actavis deal finalized

29-03-2012

Australian company QRxPharma (ASX: QRX) is moving rapidly towards the commercial phase for its lead product,…

ActavisFinancialLicensingNeurologicalPharmaceuticalQRxPharmaRegulation

2576 to 2600 of 2729 results

Back to top